Catalyst Event
Eli Lilly and Co (LLY) · Other
From Akros SCHK HK-Global Quality Factor Index (ASHGQLT)
5/26/2026, 12:00:00 AM
Announced agreements on 2026-05-26 to acquire three vaccine development companies (Curevo, LimmaTech Biologics, Vaccine Company) for up to $3.83 billion to expand its pipeline into infectious diseases. High importance is estimated as this major acquisition is expected to have a >10% price impact.
Korean Translation
2026년 5월 26일 전염병 분야 파이프라인 확장을 위해 3개의 백신 개발사를 최대 38억 3천만 달러에 인수하는 계약을 발표함. 대규모 인수에 따른 10% 이상의 주가 영향이 예상되어 중요도를 'High'로 설정함.
Related Recent Events
Eli Lilly and Co (LLY) · Earnings Release
Q2 2026 earnings release and conference call. Medium importance is estimated as earnings releases typically cause >5% price volatility scheduled.
8/5/2026, 12:00:00 AM
Lam Research Corp (LRCX) · Earnings Release
Q4 FY2026 earnings release scheduled for 2026-07-29. Estimated 1% price impact for the announcement.
7/29/2026, 12:00:00 AM
GE Vernova Inc (GEV) · Earnings Release
Q2 2026 earnings release is scheduled. This is estimated to have a low impact (~1%) as a routine announcement, scheduled.
7/22/2026, 12:00:00 AM
China Nonferrous Mining Corp Ltd (1258) · Other
Ex-dividend date for the final 2025 dividend of US$0.041446 per share on June 30, 2026, announced on March 26, 2026; Low importance is estimated due to typical minor price adjustments, scheduled.
6/30/2026, 12:00:00 AM
Lam Research Corp (LRCX) · Other
Quarterly dividend of $0.26 per share, ex-dividend date on 2026-06-17. The dividend was announced on May 21, 2026. Estimated 1% price impact as a routine corporate action.
6/17/2026, 12:00:00 AM
KLA Corp (KLAC) · Trading Issue
KLA Corp. will execute a ten-for-one forward stock split on June 12, 2026, with trading beginning on a split-adjusted basis scheduled. High importance is estimated due to the significant impact of stock splits on liquidity and retail accessibility.
6/12/2026, 12:00:00 AM